Clinical trials and research bring hope to MS patients
Stem cells and MS - AHSCT | MS Trust
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial - The Lancet
MS Trial Compares Stem Cell Treatment to Available Therapies
Trends in mesenchymal stem cell clinical trials 2004‐2018: Is efficacy optimal in a narrow dose range? - Kabat - 2020 - STEM CELLS Translational Medicine - Wiley Online Library
Clinical trials using adult stem cells to treat MS (video) - cleveland.com
Drugs in Development for Multiple Sclerosis - Practical Neurology
Israeli study: Stem cells may help multiple sclerosis brain 'repair itself' | The Times of Israel
Last 5 Years Clinical Trials Using TSCs on MS Patients (23) | Download Table
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases - The Lancet Neurology
Frontiers | Stem Cell Therapies for Progressive Multiple Sclerosis | Cell and Developmental Biology
Multiple Sclerosis and Stem Cell Treatments
Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials | Journal of Biomedical Science | Full Text
New multiple sclerosis treatment trial compares stem cell transplantation to best available drugs | National Institutes of Health (NIH)
Clinical trials using mesenchymal stem cells in MS patients | Download Scientific Diagram
Stem Cells Prove Effective in Treating MS Neural Damage
Stem cell therapy may stop and reverse MS, but risks remain | by Sparrow | Sparrow.science | Medium
/cdn.vox-cdn.com/uploads/chorus_image/image/62849285/shutterstock_1089919223.0.jpg "MS treatment: study shows chemo and stem cell transplant can reverse the disease - Vox")
MS treatment: study shows chemo and stem cell transplant can reverse the disease - Vox
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines: Trends in Molecular Medicine
Small Preliminary Study Examines Blood Stem Cell Transplant to Delay MS Progression - For The Media - JAMA Network
New Clinical Trial Compares Stem Cell Transplantation to Currently Available Drugs for MS | Technology Networks
FDA Gives Green Light for Multiple Sclerosis Stem Cell Trial | Business Wire
Stem Cell Therapy Shows 2-year Benefit for Progressive MS Patients
Clinical trials for stem cell therapies | BMC Medicine | Full Text
Shattering barriers toward clinically meaningful MSC therapies
